Brazilian Academy of Neurology practice guidelines for stroke rehabilitation: part I.

The Guidelines for Stroke Rehabilitation are the result of a joint effort by the Scientific Department of Neurological Rehabilitation of the Brazilian Academy of Neurology aiming to guide professionals involved in the rehabilitation process to reduce functional disability and increase individual autonomy. Members of the group participated in web discussion forums with predefined themes, followed by videoconference meetings in which issues were discussed, leading to a consensus. These guidelines, divided into two parts, focus on the implications of recent clinical trials, systematic reviews, and meta-analyses in stroke rehabilitation literature. The main objective was to guide physicians, physiotherapists, speech therapists, occupational therapists, nurses, nutritionists, and other professionals involved in post-stroke care. Recommendations and levels of evidence were adapted according to the currently available literature. Part I discusses topics on rehabilitation in the acute phase, as well as prevention and management of frequent conditions and comorbidities after stroke.

A randomized clinical trial on inhaled ciclesonide for managing acute asthma in the emergency room

ABSTRACT BACKGROUND: Use of inhaled corticosteroids for managing acute asthma exacerbations has been tested since the 1990s. OBJECTIVE: To compare high doses of inhaled ciclesonide with systemic hydrocortisone for managing acute asthma exacerbations in the emergency department. DESIGN AND SETTING: Double-blind, randomized clinical trial in the public healthcare system of the city of São Paulo. METHODS: Fifty-eight patients with moderate or severe asthma with peak flow < 50% of predicted were randomized into two groups. Over the course of four hours, one group received 1440 mcg of inhaled ciclesonide plus hydrocortisone-identical placebo (ciclesonide + placebo), while the other received 500 mg of intravenous hydrocortisone plus ciclesonide-identical placebo (hydrocortisone + placebo). Both groups received short-acting bronchodilators (fenoterol hydrobromide and ipratropium bromide). The research protocol included spirometry, clinical evaluation, vital signs and electrocardiogram monitoring. Data were obtained at 30 (baseline), 60, 90, 120, 180, and 240 minutes. We compared data from baseline to hour 4, between and within groups. RESULTS: Overall, 31 patients received ciclesonide + placebo and 27 received hydrocortisone + placebo. Inhaled ciclesonide was as effective as intravenous hydrocortisone for improving clinical parameters (Borg-scored dyspnea, P = 0.95; sternocleidomastoid muscle use, P = 0.55; wheezing, P = 0.55; respiratory effort, P = 0.95); and spirometric parameters (forced vital capacity, P = 0.50; forced expiratory volume in the first second, P = 0.83; peak expiratory flow, P = 0.51). CONCLUSIONS: Inhaled ciclesonide was not inferior to systemic hydrocortisone for managing acute asthma exacerbations, and it improved both clinical and spirometric parameters. TRIAL REGISTRATION: RBR-6XWC26 - Registro Brasileiro de Ensaios Clínicos (http://www.ensaiosclinicos.gov.br/rg/RBR-6xwc26/).

Brazilian Academy of Neurology practice guidelines for stroke rehabilitation: part I / Diretrizes da Academia Brasileira de Neurologia para reabilitação do acidente vascular cerebral: parte I

ABSTRACT The Guidelines for Stroke Rehabilitation are the result of a joint effort by the Scientific Department of Neurological Rehabilitation of the Brazilian Academy of Neurology aiming to guide professionals involved in the rehabilitation process to reduce functional disability and increase individual autonomy. Members of the group participated in web discussion forums with predefined themes, followed by videoconference meetings in which issues were discussed, leading to a consensus. These guidelines, divided into two parts, focus on the implications of recent clinical trials, systematic reviews, and meta-analyses in stroke rehabilitation literature. The main objective was to guide physicians, physiotherapists, speech therapists, occupational therapists, nurses, nutritionists, and other professionals involved in post-stroke care. Recommendations and levels of evidence were adapted according to the currently available literature. Part I discusses topics on rehabilitation in the acute phase, as well as prevention and management of frequent conditions and comorbidities after stroke.

RESUMO As Diretrizes Brasileiras para Reabilitação do AVC são fruto de um esforço conjunto do Departamento Científico de Reabilitação Neurológica da Academia Brasileira de Neurologia com o objetivo de orientar os profissionais envolvidos no processo de reabilitação para a redução da incapacidade funcional e aumento da autonomia dos indivíduos. Membros do grupo acima participaram de fóruns de discussão na web com pré-temas, seguidos de reuniões por videoconferência em que as controvérsias foram discutidas, levando a um consenso. Essas diretrizes, divididas em duas partes, focam as implicações de recentes ensaios clínicos, revisões sistemáticas e metanálises sobre reabilitação do AVC. O objetivo principal é servir de orientação a médicos, fisioterapeutas, fonoaudiólogos, terapeutas ocupacionais, enfermeiros, nutricionistas e demais profissionais envolvidos no cuidado pós-AVC. As recomendações e níveis de evidência foram adaptados de acordo com a literatura disponível atualmente. Aqui é apresentada a Parte I sobre tópicos de reabilitação na fase aguda, prevenção e tratamento de doenças e comorbidades frequentes após o AVC.

A randomized clinical trial on inhaled ciclesonide for managing acute asthma in the emergency room.

BACKGROUND: Use of inhaled corticosteroids for managing acute asthma exacerbations has been tested since the 1990s. OBJECTIVE: To compare high doses of inhaled ciclesonide with systemic hydrocortisone for managing acute asthma exacerbations in the emergency department. DESIGN AND SETTING: Double-blind, randomized clinical trial in the public healthcare system of the city of São Paulo. METHODS: Fifty-eight patients with moderate or severe asthma with peak flow < 50% of predicted were randomized into two groups. Over the course of four hours, one group received 1440 mcg of inhaled ciclesonide plus hydrocortisone-identical placebo (ciclesonide + placebo), while the other received 500 mg of intravenous hydrocortisone plus ciclesonide-identical placebo (hydrocortisone + placebo). Both groups received short-acting bronchodilators (fenoterol hydrobromide and ipratropium bromide). The research protocol included spirometry, clinical evaluation, vital signs and electrocardiogram monitoring. Data were obtained at 30 (baseline), 60, 90, 120, 180, and 240 minutes. We compared data from baseline to hour 4, between and within groups. RESULTS: Overall, 31 patients received ciclesonide + placebo and 27 received hydrocortisone + placebo. Inhaled ciclesonide was as effective as intravenous hydrocortisone for improving clinical parameters (Borg-scored dyspnea, P = 0.95; sternocleidomastoid muscle use, P = 0.55; wheezing, P = 0.55; respiratory effort, P = 0.95); and spirometric parameters (forced vital capacity, P = 0.50; forced expiratory volume in the first second, P = 0.83; peak expiratory flow, P = 0.51). CONCLUSIONS: Inhaled ciclesonide was not inferior to systemic hydrocortisone for managing acute asthma exacerbations, and it improved both clinical and spirometric parameters. TRIAL REGISTRATION: RBR-6XWC26 - Registro Brasileiro de Ensaios Clínicos (http://www.ensaiosclinicos.gov.br/rg/RBR-6xwc26/).

Creating cartoons to represent habitual leg movements.

Many people have a habit of moving their legs and believe that this behavior is due to the restless legs syndrome (RLS), a highly prevalent neurological condition that greatly impairs the quality of life of affected individuals. This behavioral pattern, characterized by the habit of moving one's legs and feet, may be an important confounding factor in the diagnosis of RLS. OBJECTIVE: To describe the main movements associated with this benign behavioral state to characterize a possible clinical condition that can contribute to the differential diagnosis of RLS. METHODS: Experienced sleep specialists, who primarily see RLS patients listed the most frequent movements people without RLS report while describing their suspected RLS. We first compiled a list of the lower-limb movements described by the specialists. Then, one of the authors (KC) carried out all movements of the list on camera to obtain a video footage. This footage was sent to one of the authors, EPC, who, alongside a group of students, drew graphic representations (cartoons) of the recorded movements. RESULTS: The panel of sleep experts described 13 leg movements commonly reported by their patients. The experts reported 11 simple movements and two combined movements. CONCLUSION: In this study we developed an instrument that allows us to oppose and distinguish a pathological condition (RLS) from a behavioral phenomenon. This state of behavioral leg fidgeting needs to be better characterized and may eventually be recognized as a clinical entity per se.

Creating cartoons to represent habitual leg movements / Desenvolvimento de modelos iconográficos representativos de movimentos habituais de pernas

Abstract Many people have a habit of moving their legs and believe that this behavior is due to the restless legs syndrome (RLS), a highly prevalent neurological condition that greatly impairs the quality of life of affected individuals. This behavioral pattern, characterized by the habit of moving one's legs and feet, may be an important confounding factor in the diagnosis of RLS. Objective: To describe the main movements associated with this benign behavioral state to characterize a possible clinical condition that can contribute to the differential diagnosis of RLS. Methods: Experienced sleep specialists, who primarily see RLS patients listed the most frequent movements people without RLS report while describing their suspected RLS. We first compiled a list of the lower-limb movements described by the specialists. Then, one of the authors (KC) carried out all movements of the list on camera to obtain a video footage. This footage was sent to one of the authors, EPC, who, alongside a group of students, drew graphic representations (cartoons) of the recorded movements. Results: The panel of sleep experts described 13 leg movements commonly reported by their patients. The experts reported 11 simple movements and two combined movements. Conclusion: In this study we developed an instrument that allows us to oppose and distinguish a pathological condition (RLS) from a behavioral phenomenon. This state of behavioral leg fidgeting needs to be better characterized and may eventually be recognized as a clinical entity per se.

Resumo Muitas pessoas têm o hábito de movimentar as pernas e acreditam que esse comportamento decorre da Síndrome das Pernas Inquietas (SPI), uma condição neurológica altamente prevalente com grande impacto na qualidade de vida dos indivíduos acometidos. Esse padrão de comportamento, caracterizado pelo costume de mover as pernas e os pés, pode ser um importante fator confundidor no diagnóstico da SPI. Objetivo: Descrever os principais movimentos associados a esse estado comportamental benigno, com a finalidade de caracterizar uma eventual condição clínica que possa contribuir para o diagnóstico diferencial da SPI. Métodos: Especialistas em distúrbios do sono, que atendem principalmente pacientes com SPI, listaram os movimentos que as pessoas sem SPI reportam com maior frequência enquanto descrevem a sua suspeita de síndrome. Elaboramos uma lista de movimentos dos membros inferiores descritos pelos especialistas e um dos autores (KC) realizou esses movimentos para que fossem gravados em vídeo. Essa filmagem foi enviada ao autor EPC, que, em conjunto com um grupo de alunos, realizou a representação gráfica (cartoon) dos movimentos gravados. Resultados: Os especialistas reportaram 13 movimentos de pernas, sendo 11 movimentos simples e dois movimentos combinados. Conclusão: Neste estudo, elaboramos um instrumento que permite opor, com a finalidade de diferenciá-las, uma condição patológica (SPI) de um fenômeno comportamental. Esse estado de inquietude comportamental das pernas necessita ser mais bem caracterizado, podendo eventualmente vir a ser reconhecido como uma entidade clínica per se.

Exclusion of mimics does not influence Willis-Ekbom disease diagnosis among recent medical graduates / Exclusão de fatores confundidores não influencia o diagnóstico da doença de Willis-Ekbom entre recém-formados em Medicina

ABSTRACT In view of the diagnostic challenge posed by restless legs syndrome/Willis-Ekbom disease (RLS/WED) to health professionals and the challenge of its recognition by patients, the diagnostic criteria have been revised and updated to facilitate identification of this disease. However, in a previous study, we found that self-diagnosis of RLS/WED depends on the very name used to describe the condition. Objective: To ascertain whether the presence of the fifth diagnostic criterion of the International Restless Legs Syndrome Study Group (IRLSSG), is necessary for RLS/WED diagnosis when the term "Willis-Ekbom disease" is used. Methods: We randomly distributed 705 forms to recent medical graduates, asking them to self-assess whether they had "Willis-Ekbom disease" (WED). In one questionnaire model, we excluded the fifth criterion suggested by the IRLSSG, while in the other, all five criteria were included. No forms contained the term RLS; only WED was used throughout. Results: Seven hundred and five recent medical graduates participated in the study. Among the 332 who received the form without the fifth criterion, 8 (2.41%) self-diagnosed as having WED (95%CI: 0.8%-4.1%). Of the 373 who received the form with all five of the 2014 IRLSSG criteria, 9 (2.41%) self-diagnosed as having WED (95%CI: 0.8%-4.0%) (p > 0.05). Conclusion: Our data show that presence of the fifth IRLSSG criterion did not influence self-diagnosis of WED among recent medical graduates, suggesting that the name WED reduces the odds of mimics (confounding conditions) being misinterpreted as symptoms of this disease. This finding indicates that for the diagnosis of RLS/WED only four criteria and a systematic use of the name WED are necessary.

RESUMO Frente ao desafio diagnóstico da síndrome das pernas inquietas/doença de Willis-Ekbom (SPI/DWE) pelos profissionais de saúde e também seu reconhecimento pelos pacientes, os critérios de diagnóstico vêm sendo revisados e atualizados para facilitar a identificação dessa doença, porém, em estudo anterior, observamos que o autodiagnóstico da SPI/DWE depende do próprio nome utilizado para descrevê-la. Objetivo: Verificar se a presença do quinto critério do International Restless Legs Syndrome Study Group (IRLSSG) é necessária para o diagnóstico da SPI/DWE quando utilizamos apenas a expressão/denominação DWE. Métodos: Distribuímos aleatoriamente 705 formulários solicitando a médicos recém-formados que avaliassem se eles tinham DWE. Em um tipo de questionário, excluímos o quinto critério diagnóstico sugerido pelo IRLSSG e no outro mantivemos os cinco critérios. Em nenhum formulário apresentamos o termo SPI, apenas DWE. Resultados: Setecentos e cinco médicos recém-formados participaram do estudo. Dentre os 332 médicos que receberam o formulário sem o quinto critério, 8 (2,41%) autodiagnosticaram-se com DWE (IC 95%: 0,8%-4,1%). Trezentos e setenta e três médicos receberam o formulário com os 5 critérios do IRLSSG (2014) e 9 (2,41%) autodiagnosticaram-se como tendo DWE (IC 95%: 0,8%-4,0%) (p > 0.05). Conclusão: Nossos dados mostraram que a presença do quinto critério do IRLSSG não influenciou a realização do autodiagnóstico da DWE entre médicos recém-formados, sugerindo que a denominação DWE reduz a chance de condições confundidoras serem tomadas como sintomas desta doença. Este achado está de acordo com dados anteriores, onde mostramos que o autodiagnóstico da SPI/DWE é dependente da denominação utilizada para descrever a doença.

Exclusion of mimics does not influence Willis-Ekbom disease diagnosis among recent medical graduates.

OBJECTIVE: In view of the diagnostic challenge posed by restless legs syndrome/Willis-Ekbom disease (RLS/WED) to health professionals and the challenge of its recognition by patients, the diagnostic criteria have been revised and updated to facilitate identification of this disease. However, in a previous study, we found that self-diagnosis of RLS/WED depends on the very name used to describe the condition. To ascertain whether the presence of the fifth diagnostic criterion of the International Restless Legs Syndrome Study Group (IRLSSG), is necessary for RLS/WED diagnosis when the term "Willis-Ekbom disease" is used. METHODS: We randomly distributed 705 forms to recent medical graduates, asking them to self-assess whether they had "Willis-Ekbom disease" (WED). In one questionnaire model, we excluded the fifth criterion suggested by the IRLSSG, while in the other, all five criteria were included. No forms contained the term RLS; only WED was used throughout. RESULTS: Seven hundred and five recent medical graduates participated in the study. Among the 332 who received the form without the fifth criterion, 8 (2.41%) self-diagnosed as having WED (95%CI: 0.8%-4.1%). Of the 373 who received the form with all five of the 2014 IRLSSG criteria, 9 (2.41%) self-diagnosed as having WED (95%CI: 0.8%-4.0%) (p > 0.05). CONCLUSION: Our data show that presence of the fifth IRLSSG criterion did not influence self-diagnosis of WED among recent medical graduates, suggesting that the name WED reduces the odds of mimics (confounding conditions) being misinterpreted as symptoms of this disease. This finding indicates that for the diagnosis of RLS/WED only four criteria and a systematic use of the name WED are necessary.

Benzodiazepines for restless legs syndrome.

BACKGROUND: Restless legs syndrome (RLS) is a common disease affecting about 5% to 15% of the population. Symptoms of RLS can be severe in a minority of and can have a major impact on sleep, mostly sleep initiation, and quality of life. Benzodiazepines are drugs that can induce and maintain sleep and, hence, intuitively are thought to be beneficial to people with RLS. Altough benzodiazepines, particularly clonazepam, are used to treat RLS symptoms, a systematic review done by the American Academy of Sleep Medicine stated that benzodiazepines should not be used as a first-line treatment, although could be used as a coadjuvant therapy. OBJECTIVES: To evaluate the efficacy and safety of benzodiazepine compared to placebo or other treatment for idiopathic RLS, including unconfounded trials comparing benzodiazepines versus open control. SEARCH METHODS: In March 2016 we searched CENTRAL, MEDLINE, Embase and LILACS We checked the references of each study and contacted study authors to identify any additional studies. We considered studies published in any language. SELECTION CRITERIA: Randomised clinical trials of benzodiazepine treatment in idiopathic RLS. DATA COLLECTION AND ANALYSIS: We did not perform data collection and analysis, since we did not include any studies, MAIN RESULTS: We did not identify any studies that met the inclusion criteria of the review. Two cross-over studies are awaiting classification because the cross-over trials did not give data at the end of the first cross-over period. AUTHORS' CONCLUSIONS: The effectiveness of benzodiazepines for RLS treatment is currently unknown.

Opioids for restless legs syndrome.

BACKGROUND: Restless legs syndrome (RLS) is a distressing and common neurological disorder that may have a huge impact in the quality of life of those with frequent and intense symptoms. Patients complain of unpleasant sensations in the legs, at or before bedtime, and feel an urge to move the legs, which improves with movement, such as walking. Symptoms start with the patient at rest (e.g. sitting or lying down), and follow a circadian pattern, increasing during the evening or at night. Many pharmacological intervention are available for RLS, including drugs used to treat Parkinson's disease (L-Dopa and dopaminergic agonists), epilepsy (anticonvulsants), anxiety (benzodiazepines), and pain (opioids). Dopaminergic drugs are those most frequently used for treatment of RLS, but some patients do not respond effectively and require other medication. Opioids, a class of medications used to treat severe pain, seem to be effective in treating RLS symptoms, and are recommended for patients with severe symptoms, because RLS and pain appear to share the same mechanism in the central nervous system. All available drugs are associated to some degree with side effects, which can impede treatment. Opioids are associated with adverse events such as constipation, tolerance, and dependence. This justifies the conduct of a systematic review to ascertain whether opioids are safe and effective for treatment of RLS. OBJECTIVES: To asses the effects of opioids compared to placebo treatment for restless legs syndrome in adults. SEARCH METHODS: We searched the Cochrane Central Register of Controlled trials, CENTRAL 2016, issue 4 and MEDLINE, EMBASE, and LILACS up to April 2016, using a search strategy adapted by Cochraneto identify randomised clinical trials. We checked the references of each study and established personal communication with other authors to identify any additional studies. We considered publications in all languages. SELECTION CRITERIA: Randomised controlled clinical trials of opioid treatment in adults with idiopathic RLS. DATA COLLECTION AND ANALYSIS: Two review authors independently screened articles, independently extracted data into a standard form, and assessed for risk of bias. If necessary, they discussed discrepancies with a third researcher to resolve any doubts. MAIN RESULTS: We included one randomised clinical trial (N = 304 randomised; 204 completed; 276 analysed) that evaluated opioids (prolonged release oxycodone/naloxone) versus placebo. After 12 weeks, RSL symptoms had improved more in the drug group than in the placebo group (using the IRLSSS: MD -7.0; 95% CI -9.69 to -4.31 and the CGI: MD -1.11; 95% CI -1.49 to -0.73). More patients in the drug group than in the placebo group were drug responders (using the IRLSSS: RR 1.82; 95% CI 1.37 to 2.42 and the CGI: RR1.92; 95% ICI 1.49 to 2.48). The proportion of remitters was greater in the drug group than in the placebo group (using the IRLSSS: RR 2.14; 95% CI 1.45 to 3.16). Quality of life scores also improved more in the drug group than in the placebo group (MD -0.73; 95% CI -1.1 to -0.36). Quality of sleep was improved more in the drug group measured by sleep adequacy (MD -0.74; 95% CI -1.15 to -0.33), and sleep quantity (MD 0.89; 95% CI 0.52 to 1.26).There was no difference between groups for daytime somnolence, trouble staying awake during the day, or naps during the day. More adverse events were reported in the drug group (RR 1.22; 95% CI 1.07 to 1.39). The major adverse events were gastrointestinal problems, fatigue, and headache. AUTHORS' CONCLUSIONS: Opioids seem to be effective for treating RLS symptoms, but there are no definitive data regarding the important problem of safety. This conclusion is based on only one study with a high dropout rate (moderate quality evidence).

Medindo ajustamento escolar: parâmetros psicométricos de uma escala / Measuring school adjustment: psychometric parameters of a scale / Midiendo ajuste escolar: parámetros psicométricos de una escala

O presente estudo procurou adaptar o Questionário de Ajustamento Escolar, reunindo evidências de sua validade fatorial e consistência interna. Objetivou-se ainda conhecer se suas pontuações variariam em função de sexo, série e tipo de escola dos participantes. Participaram 242 estudantes, sendo a maioria de escolas particulares (53,7%), do sexo feminino (57,7%) e com idade média de 14,3 anos (dp=1,88). A análise de componentes principais (rotação varimax) identificou quatro componentes que explicaram conjuntamente 44,5% da variância total: dificuldades disciplinares (α=0,72), dificuldades acadêmicas (α=0,65), aspectos gerais sobre a escola (α=0,59) e relacionamento com professores e estudantes (α=0,57); um fator geral apresentou Alfa de 0,78. Realizando uma MANOVA, verificou-se que houve diferença nas pontuações dos participantes do ensino médio quando comparados com aqueles do ensino fundamental no que se refere às dificuldades acadêmicas. Concluiu-se que este instrumento é psicometricamente adequado para fins de pesquisa.(AU)

This study aimed to adapt the Questionnaire of School Adjustment, jointing empirical evidences of its factor validity and reliability. Moreover, it aimed to know if its scores could vary according to the participants’ sex, scholar degree, and type of school. Participants were 242 students, most were from private school (53.7%), female (57.7%) and with mean age of 14.3 years (sd=1.88) Principal components analysis (varimax rotation) revealed four components, taking into account 44.5% of the total variance: disciplinary difficulties (α=.72), scholar difficulties (α=.65), general aspects about the school (α=.59), and relationship with professors and schoolmates (α=.57); a general component showed Alpha of .78. Performing a MANOVA, a statistical difference was observed between the participants’ scores of elementary school and high school with respect to the component named as scholar difficulties. It was concluded that this instrument is psychometric appropriated for research purpose.(AU)

Este estudio trató de adaptar el Cuestionario de Ajuste Escolar, reuniendo evidencias de su validez factorial y fiabilidad. Además, objetivó conocer si sus puntuaciones variarían según el sexo, el grado escolar y el tipo escuela de los participantes. Participaron en la investigación 242 estudiantes, la mayoría de escuelas privadas (53.7%) y mujeres (57.7%), con edad promedia de 14.3 (dt=1.88). El análisis de componentes principales (rotación varimax) identificó cuatro componentes que explicaron en conjunto un 44.5% de la varianza total: dificultades disciplinarias (α=0.72), dificultades académicas (α=0.65), aspectos generales sobre la escuela (α=0.59) y relacionamiento con profesores y estudiantes (α=0.57); un factor general presentó alfa de 0.78. Realizando una MANOVA, se constató diferencia en las puntuaciones de los participantes de enseñanza secundaria en comparación con aquellos de primaria con respecto a las dificultades académicas. Se concluyó que este instrumento es psicométricamente adecuado para fines de investigación.(AU)

Medindo ajustamento escolar: parâmetros psicométricos de uma escala / Measuring school adjustment: psychometric parameters of a scale / Midiendo ajuste escolar: parámetros psicométricos de una escala

O presente estudo procurou adaptar o Questionário de Ajustamento Escolar, reunindo evidências de sua validade fatorial e consistência interna. Objetivou-se ainda conhecer se suas pontuações variariam em função de sexo, série e tipo de escola dos participantes. Participaram 242 estudantes, sendo a maioria de escolas particulares (53,7%), do sexo feminino (57,7%) e com idade média de 14,3 anos (dp=1,88). A análise de componentes principais (rotação varimax) identificou quatro componentes que explicaram conjuntamente 44,5% da variância total: dificuldades disciplinares (α=0,72), dificuldades acadêmicas (α=0,65), aspectos gerais sobre a escola (α=0,59) e relacionamento com professores e estudantes (α=0,57); um fator geral apresentou Alfa de 0,78. Realizando uma MANOVA, verificou-se que houve diferença nas pontuações dos participantes do ensino médio quando comparados com aqueles do ensino fundamental no que se refere às dificuldades acadêmicas. Concluiu-se que este instrumento é psicometricamente adequado para fins de pesquisa...

This study aimed to adapt the Questionnaire of School Adjustment, jointing empirical evidences of its factor validity and reliability. Moreover, it aimed to know if its scores could vary according to the participants’ sex, scholar degree, and type of school. Participants were 242 students, most were from private school (53.7%), female (57.7%) and with mean age of 14.3 years (sd=1.88) Principal components analysis (varimax rotation) revealed four components, taking into account 44.5% of the total variance: disciplinary difficulties (α=.72), scholar difficulties (α=.65), general aspects about the school (α=.59), and relationship with professors and schoolmates (α=.57); a general component showed Alpha of .78. Performing a MANOVA, a statistical difference was observed between the participants’ scores of elementary school and high school with respect to the component named as scholar difficulties. It was concluded that this instrument is psychometric appropriated for research purpose...

Este estudio trató de adaptar el Cuestionario de Ajuste Escolar, reuniendo evidencias de su validez factorial y fiabilidad. Además, objetivó conocer si sus puntuaciones variarían según el sexo, el grado escolar y el tipo escuela de los participantes. Participaron en la investigación 242 estudiantes, la mayoría de escuelas privadas (53.7%) y mujeres (57.7%), con edad promedia de 14.3 (dt=1.88). El análisis de componentes principales (rotación varimax) identificó cuatro componentes que explicaron en conjunto un 44.5% de la varianza total: dificultades disciplinarias (α=0.72), dificultades académicas (α=0.65), aspectos generales sobre la escuela (α=0.59) y relacionamiento con profesores y estudiantes (α=0.57); un factor general presentó alfa de 0.78. Realizando una MANOVA, se constató diferencia en las puntuaciones de los participantes de enseñanza secundaria en comparación con aquellos de primaria con respecto a las dificultades académicas. Se concluyó que este instrumento es psicométricamente adecuado para fines de investigación...